BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38460116)

  • 1. Genetic associations with dementia-related proteinopathy: Application of item response theory.
    Katsumata Y; Fardo DW; Shade LMP; Wu X; Karanth SD; Hohman TJ; Schneider JA; Bennett DA; Farfel JM; Gauthreaux K; Mock C; Kukull WA; Abner EL; Nelson PT; ;
    Alzheimers Dement; 2024 Apr; 20(4):2906-2921. PubMed ID: 38460116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities.
    Katsumata Y; Shade LM; Hohman TJ; Schneider JA; Bennett DA; Farfel JM; ; Kukull WA; Fardo DW; Nelson PT
    Neurobiol Dis; 2022 Nov; 174():105880. PubMed ID: 36191742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
    Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
    Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study.
    Dugan AJ; Nelson PT; Katsumata Y; Shade LMP; Boehme KL; Teylan MA; Cykowski MD; Mukherjee S; Kauwe JSK; Hohman TJ; Schneider JA; ; Fardo DW
    Acta Neuropathol Commun; 2021 Sep; 9(1):152. PubMed ID: 34526147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
    James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
    Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults.
    Karanth S; Nelson PT; Katsumata Y; Kryscio RJ; Schmitt FA; Fardo DW; Cykowski MD; Jicha GA; Van Eldik LJ; Abner EL
    JAMA Neurol; 2020 Oct; 77(10):1299-1307. PubMed ID: 32568358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry.
    Katsumata Y; Fardo DW; Shade LMP; ; Nelson PT
    J Neuropathol Exp Neurol; 2023 Aug; 82(9):760-768. PubMed ID: 37528055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data.
    White CC; Yang HS; Yu L; Chibnik LB; Dawe RJ; Yang J; Klein HU; Felsky D; Ramos-Miguel A; Arfanakis K; Honer WG; Sperling RA; Schneider JA; Bennett DA; De Jager PL
    PLoS Med; 2017 Apr; 14(4):e1002287. PubMed ID: 28441426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
    Uemura MT; Robinson JL; Cousins KAQ; Tropea TF; Kargilis DC; McBride JD; Suh E; Xie SX; Xu Y; Porta S; Uemura N; Van Deerlin VM; Wolk DA; Irwin DJ; Brunden KR; Lee VM; Lee EB; Trojanowski JQ
    Acta Neuropathol; 2022 Jan; 143(1):15-31. PubMed ID: 34854996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology.
    Yang HS; White CC; Klein HU; Yu L; Gaiteri C; Ma Y; Felsky D; Mostafavi S; Petyuk VA; Sperling RA; Ertekin-Taner N; Schneider JA; Bennett DA; De Jager PL
    Neuron; 2020 Aug; 107(3):496-508.e6. PubMed ID: 32526197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive resistance to and resilience against multiple comorbid neurodegenerative pathologies and the impact of APOE status.
    Walker JM; Richardson TE
    J Neuropathol Exp Neurol; 2023 Jan; 82(2):110-119. PubMed ID: 36458951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes.
    Dugan AJ; Nelson PT; Katsumata Y; Shade LMP; Teylan MA; Boehme KL; Mukherjee S; Kauwe JSK; Hohman TJ; Schneider JA; Fardo DW;
    Neurobiol Aging; 2022 Mar; 111():95-106. PubMed ID: 34852950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels.
    Nelson PT; Gal Z; Wang WX; Niedowicz DM; Artiushin SC; Wycoff S; Wei A; Jicha GA; Fardo DW
    Neurobiol Dis; 2019 May; 125():67-76. PubMed ID: 30682540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis.
    Gauthreaux KM; Teylan MA; Katsumata Y; Mock C; Culhane JE; Chen YC; Chan KCG; Fardo DW; Dugan AJ; Cykowski MD; Jicha GA; Kukull WA; Nelson PT
    Neurology; 2022 Apr; 98(14):e1422-e1433. PubMed ID: 35121671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline.
    Chang K; Ling JP; Redding-Ochoa J; An Y; Li L; Dean SA; Blanchard TG; Pylyukh T; Barrett A; Irwin KE; Moghekar A; Resnick SM; Wong PC; Troncoso JC
    Acta Neuropathol; 2023 Dec; 147(1):4. PubMed ID: 38133681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons.
    Agrawal S; Yu L; Nag S; Arfanakis K; Barnes LL; Bennett DA; Schneider JA
    Acta Neuropathol Commun; 2021 Sep; 9(1):156. PubMed ID: 34563269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy.
    Mao F; Robinson JL; Unger T; Posavi M; Amado DA; Elman L; Grossman M; Wolk DA; Lee EB; Van Deerlin VM; Porta S; Lee VMY; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol; 2021 Oct; 142(4):629-642. PubMed ID: 34152475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.